IL-1β and IL-8, matrix metalloproteinase 3, and pepsinogen secretion before and after H pylori eradication in gastroduodenal phenotypes

被引:14
作者
Chang, Young Woon [2 ]
Oh, Hyoung-Chul [1 ]
Jang, Jae Young [2 ]
Hwangbo, Young [2 ]
Lee, Jae Won [3 ]
Lee, Hyo Jung [3 ]
Joo, Kwang Ro [2 ]
Dong, Seok Ho [2 ]
Kim, Sung Soo [4 ]
Kim, Hyo Jong [2 ]
Kim, Byung Ho [2 ]
Chang, Rin [2 ]
机构
[1] Chung Ang Univ, Coll Med, Dept Gastroenterol, Seoul 140757, South Korea
[2] Kyung Hee Univ, Dept Gastroenterol, Coll Med, Seoul, South Korea
[3] Korea Univ, Dept Stat, Seoul, South Korea
[4] Kyung Hee Univ, Dept Biochem & Mol Biol, Coll Med, Seoul, South Korea
关键词
gastroduodenal phenotypes; Helicobacter pylori; IL-1B genotypes;
D O I
10.1080/00365520802130209
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective. Relations between host genetic factors and clinical outcomes of Helicobacter pylori infection are variable among ethnicities. The aim of this study was to examine gastric mucosal cytokines, matrix metalloproteinase 3 (MMP-3), and serum pepsinogen levels before and after eradication of H. pylori according to IL-1B genotypes and benign gastroduodenal phenotypes in a Korean population. Material and methods. A total of 349 Koreans including H. pylori-infected subjects (n=230) and H. pylori-negative controls (n=119) were enrolled. The former subjects were classified into groups according to the presence of non-atrophic gastritis (n=74), atrophic gastritis (n=56), gastric ulcer (n=37), and duodenal ulcer (n=63). IL-1B polymorphisms were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Gastric mucosal IL-1 beta, IL-8, and MMP-3, and serum pepsinogen I and II levels were measured by ELISA and radioimmunoassay, respectively. Results. There were no significant differences between the IL-1B-31/-511 haplotype (TT/CC, CT/CT, and CC/TT) frequencies among the H. pylori-positive and -negative groups. The genotypes of IL-1B-31/-511 polymorphisms did not affect clinical phenotypes, inflammatory cytokines, MMP-3, and pepsinogen secretion. Subjects with H. pylori-infected atrophic gastritis exhibited significantly higher basal levels of cytokines and a lower pepsinogen I/II ratio than those of other groups. Following H. pylori eradication, inflammatory cytokines significantly decreased and the pepsinogen I/II ratio increased in all groups. Conclusions. Mucosal inflammatory cytokines, MMP-3, and pepsinogen secretion are related to gastroduodenal phenotypes but not to IL-1B genotypes. Eradication of H. pylori can reduce mucosal inflammation and restore pepsinogen secretion.
引用
收藏
页码:1184 / 1193
页数:10
相关论文
共 37 条
[1]   Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori [J].
Atherton, JC ;
Peek, RM ;
Tham, KT ;
Cover, TL ;
Blaser, MJ .
GASTROENTEROLOGY, 1997, 112 (01) :92-99
[2]   Increased production of matrix metalloproteinases in Helicobacter pylori-associated human gastritis [J].
Bergin, PJ ;
Edebo, A ;
Wen, S ;
Johnsson, E ;
Andersson, J ;
Lonroth, H ;
Michetti, P ;
Qiang, PH ;
Pan-Hammarstrom, Q .
HELICOBACTER, 2004, 9 (03) :201-210
[3]   cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors [J].
Censini, S ;
Lange, C ;
Xiang, ZY ;
Crabtree, JE ;
Ghiara, P ;
Borodovsky, M ;
Rappuoli, R ;
Covacci, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (25) :14648-14653
[4]   Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1β cytokine in Korean patients with gastric cancer [J].
Chang, YW ;
Jang, JY ;
Kim, NH ;
Lee, JW ;
Lee, HJ ;
Jung, WW ;
Dong, SH ;
Kim, HJ ;
Kim, BH ;
Lee, JI ;
Chang, R .
INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (03) :465-471
[5]  
CRABTREE JE, 1994, EUR J GASTROEN HEPAT, V6, pS33
[6]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[7]   Classification and grading of gastritis - The updated Sydney System [J].
Dixon, MF ;
Genta, RM ;
Yardley, JH ;
Correa, P ;
Batts, KP ;
Dahms, BB ;
Filipe, MI ;
Haggitt, RC ;
Haot, J ;
Hui, PK ;
Lechago, J ;
Lewin, K ;
Offerhaus, JA ;
Price, AB ;
Riddell, RH ;
Sipponen, P ;
Solcia, E ;
Watanabe, H .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (10) :1161-1181
[8]   The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer (vol 404, pg 398, 2000) [J].
El-Omar, EM ;
Carrington, M ;
Chow, WH ;
McColl, KEL ;
Bream, JH ;
Young, HA ;
Herrera, J ;
Lissowska, J ;
Yuan, CC ;
Rothman, N ;
Lanyon, G ;
Martin, M ;
Fraumeni, JF ;
Rabkin, CS .
NATURE, 2001, 412 (6842) :99-+
[9]   Interleukin-1 polymorphisms associated with increased risk of gastric cancer [J].
El-Omar, EM ;
Carrington, M ;
Chow, WH ;
McColl, KEL ;
Bream, JH ;
Young, HA ;
Herrera, J ;
Lissowska, J ;
Yuan, CC ;
Rothman, N ;
Lanyon, G ;
Martin, M ;
Fraumeni, JF ;
Rabkin, CS .
NATURE, 2000, 404 (6776) :398-402
[10]   Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan [J].
Furuta, T ;
El-Omar, EM ;
Xiao, F ;
Shirai, N ;
Takashima, M ;
Sugimurra, H .
GASTROENTEROLOGY, 2002, 123 (01) :92-105